UK Allergy Diagnostics Market (2026-2031)
The UK Allergy Diagnostics Market was valued at $251.2 Million in 2026 and projected to reach to $405.7 Million by 2031, representing a compound annual growth rate of 10.1%. The UK allergy diagnostics market is positioned for sustained growth through 2031, supported by increasing prevalence of allergic diseases, enhanced NHS funding for diagnostic capabilities, and growing patient awareness of allergy testing benefits.
UK Allergy Diagnostics Market Trends and Insights
- The UK market is driven by rising prevalence of allergic conditions, increased healthcare spending, and growing adoption of advanced diagnostic technologies across NHS and private healthcare settings.
- The UK's robust regulatory framework and emphasis on early diagnosis support sustained market expansion throughout the forecast period..
Key Market Statistics
- CAGR (2026-2031) 10.1% CAGR
- Market Size, 2026 ~USD 251.2 Million
- Forecast, 2031 ~USD 405.7 Million
- Country UK
UK Allergy Diagnostics Market Overview
Market Valuation Growth :
The UK allergy diagnostics market is valued at £251.2 million in 2026 and is projected to reach £405.7 million by 2031, demonstrating robust expansion driven by healthcare modernisation and increased diagnostic demand across the NHS and private sectors.
Strong CAGR Performance :
The UK market is growing at a CAGR of 10.1% from 2026 to 2031, outpacing the global average of 9.6%, reflecting accelerated adoption of advanced allergy diagnostic technologies and heightened clinical awareness within British healthcare systems.
NHS and Private Sector Integration :
Growth is fuelled by increased healthcare spending across both NHS trusts and private diagnostic centres, with expanding access to molecular allergy testing, component-resolved diagnostics, and immunoassay platforms across the UK healthcare landscape.
Rising Allergic Disease Prevalence :
Escalating rates of allergic conditions including food allergies, respiratory allergies, and atopic dermatitis among UK populations are driving demand for accurate, rapid diagnostic solutions and personalised allergy management strategies.
UK Allergy Diagnostics Market Dynamics
- Healthcare providers are increasingly investing in advanced diagnostic platforms including molecular testing and component-resolved diagnostics to improve clinical outcomes and reduce unnecessary allergen avoidance.
- Regulatory support from the MHRA and integration of digital health solutions are expected to further accelerate market expansion.
- The shift towards personalised medicine and preventive healthcare strategies will continue to drive demand for sophisticated allergy diagnostic tools across primary care, secondary care, and specialist allergy centres throughout the UK..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- The UK allergy diagnostics market will grow from £251.2M (2026) to £405.7M (2031) at a 10.1% CAGR.
- The UK market benefits from strong NHS integration and increasing private sector investment in diagnostic capabilities.
- Rising allergy prevalence in the UK population drives demand for accurate and rapid diagnostic solutions.
- The UK regulatory environment supports innovation and adoption of next-generation allergy testing technologies.
Allergy Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IN VITRO TESTS (Test Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 9.6% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 6.81 (2026) |
| Revenue Forecast (Billions) | ~USD 10.77 (2031) |
| Segments Covered | Product & Service, Type, Test Type, Allergen, End User |
UK Allergy Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Consumables
- Instruments
- Services
By Type
- Immunoassay Analyzers
- Luminometers
- Other In Vivo Tests
- Other Instruments
- Patch Tests
- Skin Prick Tests
By Test Type
- In Vitro Tests
- In Vivo Tests
By Allergen
- Drug Allergens
- Food Allergens
- Inhaled Allergens
- Other Allergens
By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Other End Users
Target Audience
- In Vitro Diagnostics Manufacturers : IVD companies require UK-specific market data to assess commercial viability, identify distribution partnerships with NHS procurement bodies, and develop localised product strategies for the British allergy diagnostics market.
- Healthcare Investment Firms : Private equity and venture capital investors need detailed UK market forecasts and growth drivers to evaluate investment opportunities in allergy diagnostic companies, NHS-focused service providers, and digital health platforms.
- NHS Trust Leadership : Hospital and primary care trust executives require market intelligence to justify diagnostic equipment investments, benchmark spending against peers, and plan allergy service expansion within budget constraints.
- Allergy and Immunology Specialists : Clinical specialists and allergy centres need market data to understand emerging diagnostic technologies, identify funding opportunities for service development, and advocate for improved diagnostic access across UK regions.
- Healthcare Consultants and Advisors : Management consultants and healthcare advisors require UK market insights to support client strategy development, competitive positioning, and market entry planning within the British allergy diagnostics sector.
Key Companies in the UK Allergy Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TECAN GROUP LTD. | Switzerland |
TECAN GROUP LTD.
TECAN GROUP LTD. is a Swiss life sciences company providing laboratory automation and diagnostic instruments.
Reasons to Buy this Report
- UK-Specific Market Sizing : Access precise valuation data for the UK allergy diagnostics market with detailed 2026-2031 forecasts, enabling accurate budgeting and investment decisions tailored to the British healthcare landscape.
- NHS and Private Sector Insights : Understand market dynamics across both NHS trusts and private diagnostic providers, identifying growth opportunities within different healthcare delivery models and procurement pathways specific to the UK.
- Competitive Landscape Analysis : Gain intelligence on UK-based and international diagnostic manufacturers operating in the British market, including market share, product positioning, and regulatory compliance strategies relevant to MHRA requirements.
- Growth Driver Identification : Identify key factors driving the 10.1% CAGR in the UK market, including rising allergy prevalence, healthcare spending trends, technology adoption rates, and clinical practice changes specific to British healthcare.
- Strategic Planning Support : Develop evidence-based market entry, expansion, or partnership strategies with comprehensive UK market data, regulatory insights, and stakeholder analysis to maximise commercial success in the British allergy diagnostics sector.
Frequently asked questions
What is the current size of the UK allergy diagnostics market?
The UK allergy diagnostics market is estimated at £251.2 million in 2026.
What is the projected market size for the UK by 2031?
The UK allergy diagnostics market is forecast to reach £405.7 million by 2031.
What is the growth rate of the UK allergy diagnostics market?
The UK market is expected to grow at a compound annual growth rate (CAGR) of 10.1% from 2026 to 2031.
What factors are driving growth in the UK allergy diagnostics market?
Key drivers include rising allergy prevalence, increased healthcare investment, adoption of advanced diagnostic technologies, and strong NHS support for early diagnosis.
How does the UK market compare to other European markets?
The UK's 10.1% CAGR reflects strong market fundamentals supported by established healthcare infrastructure and regulatory frameworks that encourage diagnostic innovation.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global Allergy Diagnostic market. Exhaustive secondary research was done to collect information on the allergy diagnostic market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the allergy diagnostic market's segments and subsegments.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ in-house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the allergy diagnostic market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/managing directors, marketing heads/directors and sales directors, marketing/sales managers, regional/area sales managers, export/import heads/managers, and other market-related personnel from various companies and organizations operating in the allergy diagnostic market. Primary sources from the demand side included vice presidents in hospitals & clinics, C-level executives, department heads, doctors/physicians, hospital supply management teams, clinic personnel, and laboratory technicians.
Breakdown of Primary Interviews
Note 1: C-level primaries include CEOs, COOs, and CTOs.
Note 2: Others include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the allergy diagnostic market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The market was divided into four segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth: Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of allergy diagnostic products. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
Allergy testing helps determine the substances causing a patient's allergy symptoms. Tests include skin tests, intradermal tests, challenge tests, blood tests, and patch tests. Allergists commonly conduct challenge tests, including food, inhalation, drug, and physical challenges. Blood tests are generally used when unsafe or unapplicable skin tests are required, such as when consuming certain medications or having a skin condition that may interfere with skin testing. Allergy tests, such as in vitro & in vivo tests, are performed to determine the cause, stage, prognosis, and treatment course for allergic diseases.
Key Stakeholders
- Allergy Diagnostic Reagents, Kits, and Instrument Manufacturers
- Allergy Diagnostic Vendors and Distributors
- Hospitals
- Diagnostic Laboratories
- Allergy Diagnostic Service Providers
- Academic Research Institutes
- Venture Capitalists and Investors
- Contract Research Organizations (CROs)
Report Objectives
- To describe, analyze, and forecast the allergy diagnostic market, by product & service, test type, allergen, end user, and region
- To describe and forecast the allergy diagnostic market for key regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the allergy diagnostic market
- To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s Five Forces, and prices pertaining to the market under study
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the allergy diagnostic market
- To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the allergy diagnostic market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific allergy diagnostic market into Vietnam, New Zealand, and others
- Further breakdown of the Rest of Latin America allergy diagnostic market into Colombia, Chile, Ecuador, and others
- Further breakdown of the Rest of Europe allergy diagnostic market into Belgium, Russia, the Netherlands, Switzerland, and others
Get the Full Allergy Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Allergy Diagnostics Market.
- Canada Allergy Diagnostics Market
- US Allergy Diagnostics Market
- Germany Allergy Diagnostics Market
- France Allergy Diagnostics Market
- Italy Allergy Diagnostics Market
- Spain Allergy Diagnostics Market
- China Allergy Diagnostics Market
- Japan Allergy Diagnostics Market
- India Allergy Diagnostics Market
- South Korea Allergy Diagnostics Market
- Australia Allergy Diagnostics Market
- Brazil Allergy Diagnostics Market
- Mexico Allergy Diagnostics Market
- GCC Countries Allergy Diagnostics Market
- Rest Of Europe Allergy Diagnostics Market
- Rest Of Asia Pacific Allergy Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report